A patient’s perspective on biomarker testing in non-small cell lung cancer

Understanding the Challenges of Universal Biomarker TestingПодробнее

Episode 157: Biomarker Testing Improves Outcomes for Patients With Non-Small Cell Lung CancerПодробнее

Catalyzing Lung Cancer Care | The Transformative Impact of Early Biomarker TestingПодробнее

Lung Cancer Biomarker Testing: Improving Turnaround from Presentation to TreatmentПодробнее

HCP Roundtable: Improving Clinician-Patient Conversations in Lung Cancer Biomarker TestingПодробнее

Patient-Provider Relationship Role in Lung Cancer Biomarker TestingПодробнее

FDA Patient Listening Session "Drug Development in Molecular Subsets of Non-Small Cell Lung Cancer"Подробнее

Biomarker testing in lung cancer | Mark's perspectiveПодробнее

When Should Lung Cancer Patients Receive Biomarker Testing?Подробнее

Deborah’s Experience with Non-Small Cell Lung CancerПодробнее

NCCN Patient Webinar: Small Cell Lung CancerПодробнее

Surgeons and Comprehensive Biomarker Testing for Lung Cancer Patients, November 4, 2021Подробнее

Treatment Options for Late-Stage Lung Cancer - 4/19/22 - Lung Cancer Living Room™Подробнее

Unlock KRAS G12C for lung cancer treatment decisionsПодробнее

Lung Cancer Biomarker TestingПодробнее

The Significance of Biomarker Testing in Patient IdentificationПодробнее

Practical Principles of Biomarker Testing in Advanced Non-Small Cell Lung CancerПодробнее

How Does Biomarker Testing Impact Non-Small Cell Lung Cancer Care?Подробнее

Biomarker Testing for Lung Cancer WebinarПодробнее

Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLCПодробнее